Bionano Genomics, Inc.
(NASDAQ : BNGO)

( )
BNGO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -1.62%199.190.0%$1686.05m
BIIBBiogen, Inc. 1.28%388.441.7%$1298.22m
SNSSSunesis Pharmaceuticals, Inc. 5.98%12.760.7%$891.97m
NVAXNovavax, Inc. -3.05%174.4179.8%$677.69m
AMGNAmgen, Inc. -0.86%238.681.3%$653.84m
BNTXBioNTech SE -0.83%212.420.0%$524.93m
VRTXVertex Pharmaceuticals, Inc. -0.27%187.851.9%$517.31m
GILDGilead Sciences, Inc. -0.91%66.611.0%$493.35m
REGNRegeneron Pharmaceuticals, Inc. 0.36%537.922.7%$384.81m
ILMNIllumina, Inc. 0.18%456.163.5%$365.16m
ALXNAlexion Pharmaceuticals, Inc. 0.40%180.692.0%$338.92m
OCGNOcugen, Inc. 0.00%6.540.0%$285.39m
EXASEXACT Sciences Corp. -0.30%126.5218.1%$189.07m
TXG10X Genomics, Inc. -2.18%194.430.0%$173.74m
BNGOBionano Genomics, Inc. -3.05%7.620.0%$165.33m

Company Profile

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.